Prosecution Insights
Prosecution Insights
6 pending office actions • 5 art units • 5 examiners • 0 of 6 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (17%) |
| §103 only | 2 (33%) |
| §102 only | 2 (33%) |
| Multi-statute (no §101) | 1 (17%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| JOS, BASIL T | 2 | 77.7% | +6.4% |
| RIGA, MICHAEL ANGELO | 1 | 56.7% | +59.7% |
| EBBINGHAUS, BRIANA NOEL | 1 | 62.3% | +61.4% |
| LEPAGE, JONATHAN EVERETT | 1 | 53.6% | +33.3% |
| HENKEL, DANIELLE B | 1 | 56.4% | +23.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18146897 | METHOD FOR PRODUCING NERVE CELL, METHOD FOR PRODUCING MOTOR NEURON, AND METHOD FOR SCREENING NEUROLOGICAL DISEASE THERAPEUTIC DRUG | EBBINGHAUS, BRIANA NOEL | 100d overdue |
| 18615184 | METHOD FOR SCREENING SUBSTANCE, SYSTEM FOR SCREENING SUBSTANCE, METHOD FOR PRODUCING A CLUMP FROM STEM CELLS, AND METHOD FOR PRODUCING DIFFERENTIATED CELLS | RIGA, MICHAEL ANGELO | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18146897 | METHOD FOR PRODUCING NERVE CELL, METHOD FOR PRODUCING MOTOR NEURON, AND METHOD FOR SCREENING NEUROLOGICAL DISEASE THERAPEUTIC DRUG | EBBINGHAUS, BRIANA NOEL | 100d overdue |
| 17637798 | CELL PRODUCTION DEVICE AND SYSTEM THEREFOR | HENKEL, DANIELLE B | 45d overdue |
| 18615184 | METHOD FOR SCREENING SUBSTANCE, SYSTEM FOR SCREENING SUBSTANCE, METHOD FOR PRODUCING A CLUMP FROM STEM CELLS, AND METHOD FOR PRODUCING DIFFERENTIATED CELLS | RIGA, MICHAEL ANGELO | — |
| 17638735 | CELL PRODUCTION DEVICE | LEPAGE, JONATHAN EVERETT | — |
| Art Unit | Apps |
|---|---|
| 3656 | 2 |
| 1653 | 1 |
| 1632 | 1 |
| 1796 | 1 |
| 1799 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19251801 | CELL PRODUCTION SYSTEM | JOS, BASIL T | 3656 | §102 | Non-Final OA | — | Pending | Jun 27, 2025 |
| 19251802 | CELL PRODUCTION SYSTEM | JOS, BASIL T | 3656 | §102 | Non-Final OA | — | Pending | Jun 27, 2025 |
| 18615184 | METHOD FOR SCREENING SUBSTANCE, SYSTEM FOR SCREENING SUBSTANCE, METHOD FOR PRODUCING A CLUMP FROM STEM CELLS, AND METHOD FOR PRODUCING DIFFERENTIATED CELLS | RIGA, MICHAEL ANGELO | 1653 | §101§102§112 | Non-Final OA | — | Pending | Mar 25, 2024 |
| 18146897 | METHOD FOR PRODUCING NERVE CELL, METHOD FOR PRODUCING MOTOR NEURON, AND METHOD FOR SCREENING NEUROLOGICAL DISEASE THERAPEUTIC DRUG | EBBINGHAUS, BRIANA NOEL | 1632 | §103§112 | Final Rejection | 100d overdue | Pending | Dec 27, 2022 |
| 17638735 | CELL PRODUCTION DEVICE | LEPAGE, JONATHAN EVERETT | 1796 | §103 | Non-Final OA | — | Pending | Feb 25, 2022 |
| 17637798 | CELL PRODUCTION DEVICE AND SYSTEM THEREFOR | HENKEL, DANIELLE B | 1799 | §103Other | Final Rejection | 45d overdue | Pending | Feb 23, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial